SRL

Business Context and Reporting Period

Company: MFC Bancorp Ltd. (Note: Input metadata referenced "Scully Royalty Ltd.", but the filing text identifies the registrant as MFC Bancorp Ltd.)
Filing Type: Form 6-K (Quarterly Report)
Reporting Period: Three and six months ended June 30, 2016
Filing Date: August 15, 2016
Business Overview: A merchant bank with diversified finance and supply chain operations and other investments. The company actively seeks investments where its financial expertise can add value. Operations are divided into "Finance and Supply Chain" and "All Other" segments.

Key Financial Metrics

All figures in Canadian dollars (CAD) unless otherwise noted.

Material Changes vs. Prior Period

• Revenue Decline: Revenues decreased by approximately 12% year-over-year, primarily due to the exiting of certain product lines and geographical markets. This was partially offset by a weaker Canadian dollar against the Euro.
• Profitability Drop: Net income from continuing operations fell significantly from $11.7 million to $0.7 million. The company reported a net loss for the period when including discontinued operations.
• Inventory Rationalization: Inventories were reduced by over $90.6 million (from $245.3 million to $154.7 million) as the company exited underperforming product lines.
• Receivables Increase: Trade receivables increased to $184.4 million from $151.2 million, attributed to inventory reduction timing and recoveries from a former insolvent customer.
• Currency Impact: A strengthening Canadian dollar resulted in a non-cash currency translation adjustment loss of $20.3 million, reducing net book value.
• Debt Structure: Short-term bank borrowings increased significantly to finance trade receivables and payables, while long-term debt decreased slightly.

Guidance, Outlook, and Material Events

• Asset Rationalization: Management expressed disappointment with results, citing too much capital in underperforming assets. The strategy involves selling these assets to reinvest in higher-return projects.
• Sale of Fesil Rana Metall AS: In August 2016, the company agreed to sell its Norwegian ferrosilicon plant and Spanish quartz quarries to Elkem AS for cash approximately equal to net asset value. Elkem will also purchase the associated inventory.
• Expansion in China: The company's subsidiary, Mednet Nephrology Group Ltd., is entering the outpatient hemodialysis market in China, targeting a growing population of End Stage Renal Disease (ESRD) patients.
• Customer Recovery: The company recognized a $35.1 million gain in Q2 2016 related to recoveries from a former customer who filed for insolvency in Q1 2016. However, a prudent unallocated reserve of $33.3 million remains.
• Share Price Discount: As of August 12, 2016, the share price traded at a 47% discount to book value. Management attributes this to a lack of liquidity caused by a small number of shareholders controlling 55% of the shares.
• Internal Controls: The company reported that material weaknesses in internal controls identified in 2015 (related to complex accounting on contingent liabilities and revenue presentation) have been remediated.

Investor Verification Checklist

• Inventory Valuation: Verify the fair market value of remaining inventories ($154.7 million) and the extent of hedging ($66.9 million contracted/hedged).
• Receivables Quality: Assess the collectability of the increased trade receivables ($184.4 million) and the sufficiency of the $33.3 million reserve for the former insolvent customer.
• Divestiture Closing: Monitor the closing conditions and regulatory approvals for the sale of Fesil Rana Metall AS to Elkem AS.
• Liquidity Position: Review the sustainability of the increased short-term borrowings ($184.3 million) relative to cash flow from operations.
• China Expansion Risks: Evaluate the execution risks and capital requirements for the new hemodialysis operations in China.
• Shareholder Structure: Investigate management's plans to address the liquidity discount caused by concentrated share ownership.